FDA's qualifications on GUSTO

WASHINGTON - The FDA approved the accelerated infusion regimen of Genentech Inc.'s Activase tPA. Physicians now may administer the drug over

Read the full 214 word article

How to gain access

Continue reading with a
two-week free trial.